Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | PROKR1 | Q8TCW9 | 10/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4974838 | 1.00 | KMT2A (0.40) | KMT2AALDH1A1MEN1PROKR1RAB9A | |
| SCHEMBL2327230 | 0.85 | CNR1 (0.46) | KMT2AALDH1A1MEN1RAB9AMAPT | |
| SCHEMBL2327223 | 0.85 | CNR1 (0.46) | KMT2AALDH1A1MEN1RAB9AMAPT | |
| SCHEMBL2327226 | 0.85 | CNR1 (0.46) | KMT2AALDH1A1MEN1RAB9AMAPT | |
| SCHEMBL28779404 | 0.83 | KDM4E (0.42) | KMT2AMEN1HTTSMN1; SMN2 | |
| SCHEMBL3963369 | 0.81 | TSHR (0.41) | KMT2AALDH1A1MEN1RAB9ATSHR | |
| SCHEMBL4974885 | 0.78 | TSHR (0.42) | KMT2AALDH1A1MEN1PROKR1TSHR | |
| SCHEMBL4974880 | 0.78 | TSHR (0.42) | KMT2AALDH1A1MEN1PROKR1TSHR | |
| SCHEMBL4193014 | 0.78 | REN (0.59) | — | |
| SCHEMBL4193008 | 0.78 | REN (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1966139-A1 | ASPARTIC PROTEASE INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007070201-A1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |